Quantitative SSTR-PET/CT for Predicting Response and Survival Outcomes in Patients with Pancreatic Neuroendocrine Tumors Receiving CAPTEM. Radiology and Oncology, v. 57, n. 4, p. 436–445, 27 Nov.2023.